Drug intelligence / Profile preview

lidocaine + magnesium

Development stage
Approved
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Intravenous
01

Overview

Lidocaine + magnesium is a combination of two agents—lidocaine, an amide-type local anesthetic and antiarrhythmic, and magnesium (typically administered as magnesium sulfate), an essential mineral with neuromodulatory properties. This combination is used intravenously in perioperative settings for multimodal anesthesia or for the management of intractable neuropathic pain. Lidocaine acts primarily by blocking voltage-gated sodium channels on neuronal membranes, stabilizing them and inhibiting the initiation and conduction of nerve impulses. Magnesium exerts analgesic effects mainly through antagonism of N-methyl-D-aspartate (NMDA) receptors, reducing central sensitization to pain. When combined, these drugs have been shown to provide opioid-sparing effects during surgery, improve hemodynamic stability under general anesthesia without prolonging neuromuscular blockade recovery time beyond that caused by magnesium alone, and offer relief in cases of refractory neuropathic pain such as trigeminal neuralgia[1][2][5][8].

Other names
lidocaine and magnesiumlidocaine plus magnesiumlidocaine + magnesium sulfate
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)Naᵥ1.1 (Sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on lidocaine + magnesium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + magnesium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call